EUCTR2006-003369-14-DE进行中（未招募）不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patient presenting with the following criteria may be included:
- •- under 18 year-old male or female ambulatory patient,
- •- suffering from an ichthyosis, excepted bullous forms of the disease, with symmetric lesions,
- •- having a SRRC score sup. or equal to 4 on both external face of the legs,
- •- with scaling sup. or equal to 2 (on the SRRC score) on both external face of the legs,
- •- willing and able to understand and sign an approved Informed Consent Form, and/or whose parent(s) or guardian(s) has(have) given his/her(their) written consent for their child's participation in the study,
- •- able to understand the protocol and to attend the control visits, and/or whose parent(s) or guardian(s) is(are) cooperative with regard to compliance with study-related constraints.
- •- if required by national regulations, registered with a social security or health insurance system.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients presenting with any of the following criteria will not be included:
- •* Criteria related to pathologies·
- •- Severe forms of ichthyosis requiring an hospitalisation,·
- •- Dermatological disease other than ichthyosis liable to interfere with the assessment,·
- •- History of serious disease considered by the investigator hazardous for the patient or incompatible with the study.
- •* Criteria related to treatments·
- •- History of allergy or intolerance to the study drug or its excipients, or to cosmetics,·
- •- Treatment by systemic retinoids started or modified during the last 2 months,·
- •- Homeopathic treatment during the last 2 months,
- •- Treatment by local retinoids, topical or systemic corticosteroids (injectable, oral), tazarotene, calcipotriol during the last month,
- •- Treatment by keratinolytics such as urea, propylene glycol, polyethylene glycol, salicylic acid, alphahydroxy acids, N-acetylcysteine during the last week,
- •- Treatment by UV-B therapy during the last week,·
- •- Treatment by UV-A therapy.
- •* Criteria related to the way of life·
- •- Use of food supplements able to modify skin (vitamin A …) during the study duration,·
- •- Practice of swimming pool, sauna, hammam, spa, UV during the study,·
- •- Immoderate use of alcohol or tobacco.
- •* Criteria related to the population·
- •- Parent(s) or guardian(s) linguistically or psychologically unable to understand the information given or to give his/her(their) informed consent or who refuses(refuse) to give his/her(their) consent in writing, or patient linguistically or psychologically unable to understand the information given or formulate his/her informed consent or who refuses to give his/her consent in writing,
- •- Parent(s) or guardian(s) subject to an administrative or court order or subject to guardianship or wardship or patient subject to an administrative or court order or subject to guardianship or wardship,·
- •- Parent(s) or guardian(s) who cannot be contacted by telephone in an emergency, or patient who cannot be contacted by telephone in an emergency,
- •- Participation to another clinical trial in the previous month or during the study.
- •- known pregnancy or breast feeding.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-ESPIERRE FABRE MEDICAMENT265
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-FIPIERRE FABRE MEDICAMENT270
进行中（未招募）
1 期
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-FRPIERRE FABRE MEDICAMENT265
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.Patients presenting with ichthyosisMedDRA version: 8.1Level: LLTClassification code 10021198Term: IchthyosisEUCTR2006-003369-14-LTPIERRE FABRE MEDICAMENT270
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-LVPIERRE FABRE MEDICAMENT270